Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 2/3 1

Status

Completed 4

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Prostatic Neoplasms 24Neoplasm Metastasis 7Neoplasms 5Prostate Cancer Metastatic 4Carcinoma, Transitional Cell 4Recurrence 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Solid Cancer 1Small Cell Lung Carcinoma 1Penile Neoplasms 1Ovarian Neoplasms 1Nonseminomatous germ cell tumor 1Neoplastic Cells, Circulating 1Metastatic Castration-resistant Prostate Cancer 1Malignant Solid Tumor - Malignant Nervous System Neoplasm 1Lymphadenopathy 1Liposarcoma 1Hormone Refractory Prostate Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Breast Neoplasms 1Bone Metastatic Prostate Cancer 1Advanced Solid Tumor 1

Interventions

pembrolizumab 25Gemcitabine 21Nivolumab 17Cisplatin 17atezolizumab 14Carboplatin 11avelumab 9vinflunine 7Ipilimumab 7Paclitaxel 6Docetaxel 5enfortumab vedotin 4cabazitaxel 4Pemetrexed 4Mitomycin 4cabozantinib 3Taxes 3Rogaratinib 3Magnetic Resonance Spectroscopy 3Injections 3Albumin-Bound Paclitaxel 3tremelimumab 2sacituzumab govitecan 2pemigatinib 2niraparib 2lenvatinib 2bempegaldesleukin 2apatorsen 2XRP6258 2Vitamin D 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Carcinoma, Transitional Cell × cabazitaxel × Clear all
NCT01616875 2026-03-06

Bristol Bladder Trial

University Hospitals Bristol and Weston NHS Foundation Trust

Phase 2 Completed
28 enrolled 21 charts
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT01437488 2025-05-04

Cabazitaxel in Patients With Urothelial Carcinoma Who Have Disease Progression Following Platinum-Based Chemotherapy

Thomas Jefferson University

Phase 2 Completed
14 enrolled 12 charts
Genitourinary

Carcinoma, Transitional Cell

NCT01668459 2018-12-04

CabB1

University Hospital Birmingham NHS Foundation Trust

Phase 2/3 Completed
20 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Neoplasms

NCT01600339 2015-05-12

A Trial of Cabazitaxel for Advanced Transitional Cell Carcinoma (TCC)

Rambam Health Care Campus

Phase 2 Completed
19 enrolled
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡